Laboratory testing for HER2/neu in breast carcinoma: an evolving strategy to predict response to targeted therapy. [electronic resource]
Producer: 20011204Description: 415-8 p. digitalISSN:- 1073-2748
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- therapeutic use
- Breast Neoplasms -- diagnosis
- False Positive Reactions
- Female
- Gene Amplification
- Genes, erbB-2
- Humans
- Immunohistochemistry
- In Situ Hybridization, Fluorescence
- Neoplasm Proteins -- analysis
- Prognosis
- Receptor, ErbB-2 -- analysis
- Trastuzumab
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.